Chargement…
Toutes les entreprises d’ici passées par les mêmes cinq vérifications sur la croissance et la génération de trésorerie. Cela décrit le sous-secteur tel qu’il publie aujourd’hui — pas laquelle de ces valeurs acheter.
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | C | 50,4B $US | 43,21 $US | 100,49 | 17,2B $US | 2,9 % |
| HLN | Haleon plc | B+ | 40,7B $US | 9,09 $US | 18,33 | 14,8B $US | 15,1 % |
| ZTS | Zoetis Inc. | C+ | 33,5B $US | 82,57 $US | 13,92 | 9,5B $US | 26,4 % |
| TAK | Takeda Pharmaceutical Company Limited | A | 33,5B $US | 20,86 $US | 48,79 | 29,8B $US | 0,9 % |
| UTHR | United Therapeutics Corporation | C+ | 25,4B $US | 595,58 $US | 22,48 | 3,2B $US | 38,6 % |
| VTRS | VIATRIS INC. | D | 24,1B $US | 21,06 $US | — | 14,7B $US | -23,9 % |
| NBIX | NEUROCRINE BIOSCIENCES, INC. | A+ | 17,6B $US | 174,35 $US | 25,87 | 3,7B $US | 19,0 % |
| ELAN | Elanco Animal Health Incorporated | A | 13,2B $US | 26,48 $US | — | 5,1B $US | -2,9 % |
| RDY | DR. REDDY’S LABORATORIES LIMITED | B | 12,4B $US | 14,83 $US | 20,77 | 3,5B $US | 4,4 % |
| KNSA | Kiniksa Pharmaceuticals International, plc | A+ | 8,1B $US | 95,80 $US | 73,13 | 946M $US | 11,6 % |
| ALKS | Alkermes plc. | C | 8B $US | 47,88 $US | — | 1,8B $US | -0,0 % |
| AMRX | Amneal Pharmaceuticals, Inc. | C | 7,6B $US | 21,72 $US | 51,71 | 3,2B $US | 4,2 % |
| LNTH | LANTHEUS HOLDINGS, INC. | B+ | 6,6B $US | 101,58 $US | 25,08 | 1,6B $US | 17,3 % |
| LQDA | LIQUIDIA CORPORATION | A | 5B $US | 55,19 $US | — | 621,9M $US | -15,1 % |
| HIMS | HIMS & HERS HEALTH, INC. | C- | 4,9B $US | 20,81 $US | — | 2,9B $US | -6,7 % |
| AMLX | Amylyx Pharmaceuticals, Inc. | D | 4,1B $US | 31,78 $US | — | 0,00 $US | — |
| BHC | Bausch Health Companies Inc. | A | 3,1B $US | 8,35 $US | — | 11,1B $US | -7,6 % |
| XERS | XERIS BIOPHARMA HOLDINGS, INC. | F- | 3B $US | 16,51 $US | — | 368,3M $US | -1,8 % |
| RGC | REGENCELL BIOSCIENCE HOLDINGS LIMITED | non notée | 2,7B $US | 5,45 $US | — | — | — |
| HCM | HutchMED (China) LIMITED | D | 2,6B $US | 15,04 $US | — | 549,1M $US | 3,3 % |
| PRGO | Perrigo Company plc | F- | 2,3B $US | 16,56 $US | — | 4,1B $US | -43,3 % |
| TRLV | TRULIEVE CANNABIS CORP. | F | 2,3B $US | 11,24 $US | — | 1,1B $US | -41,3 % |
| PBH | PRESTIGE CONSUMER HEALTHCARE INC. | C+ | 2,1B $US | 44,17 $US | 13,63 | 1,2B $US | 13,3 % |
| ETON | ETON PHARMACEUTICALS, INC. | A+ | 2B $US | 68,42 $US | — | 141,1M $US | 35,3 % |
| BCRX | BIOCRYST PHARMACEUTICALS, INC. | B | 2B $US | 7,65 $US | — | 961,5M $US | -37,4 % |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | B | 1,7B $US | 29,42 $US | — | 865,1M $US | -5,1 % |
| ANIP | ANI PHARMACEUTICALS, INC | B+ | 1,5B $US | 71,23 $US | 14,22 | 1B $US | 11,2 % |
| ALVO | ALVOTECH | B | 1,5B $US | 4,93 $US | 49,25 | 586,3M $US | 4,8 % |
| PCRX | PACIRA BIOSCIENCES, INC. | B | 1,5B $US | 36,47 $US | 39,22 | 743,3M $US | 5,1 % |
| PAHC | Phibro Animal Health Corporation | B | 1,4B $US | 35,13 $US | 14,00 | 1,5B $US | 6,7 % |
| CRON | CRONOS GROUP INC. | A | 1,3B $US | 3,46 $US | 20,32 | 206,2M $US | 28,0 % |
| AMPH | Amphastar Pharmaceuticals, Inc. | B+ | 1,2B $US | 28,61 $US | 13,06 | 745,8M $US | 13,3 % |
| HROW | Harrow, Inc. | D- | 1,1B $US | 29,30 $US | — | 303,3M $US | -9,4 % |
| BGM | BGM Group Ltd | F- | 985,4M $US | 8,70 $US | — | 47,9M $US | -44,2 % |
| IRWD | IRONWOOD PHARMACEUTICALS INC | C+ | 804,6M $US | 4,86 $US | 5,40 | 400,3M $US | 37,4 % |
| COLL | Collegium Pharmaceutical, Inc. | B | 770,5M $US | 24,80 $US | 24,80 | 815,2M $US | 4,7 % |
| TKNO | ALPHA TEKNOVA, INC. | B- | 541,6M $US | 8,61 $US | — | 46M $US | -34,8 % |
| EOLS | EVOLUS, INC. | B | 492,1M $US | 7,44 $US | — | 325,5M $US | -9,6 % |
| KMDA | KAMADA LTD | C+ | 469,6M $US | 8,14 $US | 18,93 | 196,9M $US | 13,6 % |
| AQST | Aquestive Therapeutics, Inc. | D | 449,3M $US | 3,58 $US | — | 48,8M $US | -162,3 % |
| TLRY | Tilray Brands, Inc. | C- | 385M $US | 2,61 $US | — | 963,1M $US | -17,1 % |
| EBS | EMERGENT BIOSOLUTIONS INC. | D | 310,3M $US | 6,04 $US | — | 649,1M $US | -40,2 % |
| EVO | Evotec SE | F- | 304,9M $US | 1,72 $US | — | 836,2M $US | -26,0 % |
| ACB | AURORA CANNABIS INC | D- | 280,9M $US | 5,05 $US | 176,32 | 225,8M $US | -29,9 % |
| BIOA | BIOAGE LABS, INC. | F- | 268,9M $US | 5,85 $US | — | 8,6M $US | -1 253,6 % |
| CGC | Canopy Growth Corporation | C- | 256,3M $US | 0,61 $US | — | 219,2M $US | -87,0 % |
| LFCR | LIFECORE BIOMEDICAL, INC. | F | 242,4M $US | 6,40 $US | — | 128,9M $US | -30,0 % |
| SIGA | Siga Technologies INC | F | 225,6M $US | 3,14 $US | — | 52,4M $US | 1,3 % |
| INCR | INTERCURE LTD. | C- | 219,8M $US | 4,02 $US | — | 86,4M $US | -13,2 % |
| ADCT | ADC Therapeutics SA | C | 203,6M $US | 1,60 $US | — | 84,9M $US | -95,7 % |
| ANIK | Anika Therapeutics, Inc. | B- | 186,3M $US | 13,91 $US | — | 123,4M $US | -1,4 % |
| GLAS | Glass House Brands Inc. | F- | 165,5M $US | 1,90 $US | — | 152,9M $US | -33,7 % |
| AKBA | AKEBIA THERAPEUTICS, INC. | D | 158M $US | 0,57 $US | — | 197,2M $US | -22,6 % |
| ORGO | ORGANOGENESIS HOLDINGS INC. | F- | 136,3M $US | 1,05 $US | — | 352M $US | -38,4 % |
| DERM | Journey Medical Corp | C- | 125,7M $US | 4,46 $US | — | 68,2M $US | -9,0 % |
| CRDL | Cardiol Therapeutics Inc. | non notée | 100,8M $US | 1,01 $US | — | — | — |
| CPIX | Cumberland Pharmaceuticals Inc. | F- | 94,8M $US | 6,33 $US | — | 39,9M $US | -27,4 % |
| INM | INMED PHARMACEUTICALS INC. | F- | 85,5M $US | 15,56 $US | — | 4,5M $US | -292,1 % |
| OGI | ORGANIGRAM HOLDINGS INC. | C- | 81,3M $US | 0,85 $US | — | 185,5M $US | -9,6 % |
| ZYBT | Zhengye Biotechnology Holding Limited | D | 72,3M $US | 1,53 $US | — | 17,5M $US | -60,0 % |
| CTOR | Citius Oncology, Inc. | non notée | 51,7M $US | 0,56 $US | — | — | — |
| SCYX | SCYNEXIS INC | F- | 34,1M $US | 3,43 $US | — | 18,9M $US | -53,5 % |
| RMTI | ROCKWELL MEDICAL, INC. | B- | 28,7M $US | 7,13 $US | — | 72,6M $US | -7,8 % |
| CPHI | CHINA PHARMA HOLDINGS, INC. | D- | 22,7M $US | 0,53 $US | — | 3,9M $US | -114,3 % |
| TXMD | TherapeuticsMD, Inc. | F- | 21,4M $US | 1,85 $US | — | 3,3M $US | -6,6 % |
| AYTU | AYTU BIOPHARMA, INC. | C | 19,7M $US | 1,82 $US | — | 57,6M $US | -24,8 % |
| RDHL | REDHILL BIOPHARMA LTD. | F | 17,9M $US | 0,40 $US | — | -3,7M $US | -72,5 % |
| TLPH | TALPHERA, INC. | D- | 15M $US | 1,05 $US | — | 1K $US | -1 465 800,0 % |
| BFRI | Biofrontera Inc. | B- | 13,9M $US | 0,93 $US | — | 46,2M $US | -13,8 % |
| SBFM | Sunshine Biopharma Inc. | D- | 10,7M $US | 2,76 $US | — | 35,3M $US | -16,5 % |
| CABR | Caring Brands, Inc. | F- | 9,2M $US | 0,88 $US | — | 4,2K $US | -183 255,2 % |
| IMCC | IM Cannabis Corp. | D | 7,2M $US | 0,56 $US | — | 32,8M $US | -40,1 % |
| SNOA | SONOMA PHARMACEUTICALS, INC. | C- | 6,2M $US | 1,23 $US | — | 23,5M $US | -7,6 % |
| SHPH | SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | non notée | 5,4M $US | 5,32 $US | — | — | — |
| GELS | Gelteq Limited | D- | 4M $US | 0,43 $US | — | 116,4K $US | -4 011,9 % |
| APUS | APIMEDS PHARMACEUTICALS US, INC. | non notée | 3,4M $US | 2,28 $US | — | — | — |
| SXTC | China SXT Pharmaceuticals, Inc. | F- | 2,8M $US | 2,89 $US | — | 1,1M $US | -545,2 % |
| YCBD | cbdMD, Inc. | D- | 1,6M $US | 0,39 $US | — | 20,9M $US | -13,8 % |
| IXHL | Incannex Healthcare Inc. | F- | 993,5K $US | 1,98 $US | — | 0,00 $US | — |
| UPC | Universe Pharmaceuticals INC | D- | 907K $US | 1,61 $US | — | 17,9B $US | -20,6 % |
| PRFX | PRF Technologies Ltd. | B- | 629,5K $US | 0,76 $US | — | 17K $US | -29 541,2 % |
| AKAN | Akanda Corp. | F | 50,4K $US | 0,73 $US | — | 258,1K $US | -19 775,5 % |
| INDV | Indivior Pharmaceuticals, Inc. | A | — | 28,15 $US | — | 1,4B $US | 32,8 % |
| OPTH | Optimi Health Corp. | non notée | — | 2,19 $US | — | — | — |
Fondamentaux issus des documents déposés auprès de la SEC, cours issus de la dernière collecte de données de marché. Triez par n’importe quelle colonne ; les entreprises sans chiffre passent en dernier dans les deux sens.
Trié par capitalisation, de la plus grande à la plus petite ; cliquez sur une colonne pour retrier. Les entreprises sans chiffre passent en dernier dans les deux sens, parce qu’un PER manquant signifie une perte et non un titre bon marché. Rien ici n’est une recommandation.